Preventing T cell rejection of pig xenografts

International Journal of Surgery

Volumn 23, Issue , 2015, Pages 285-290

  Higginbotham, Laura ^a   Ford, Mandy L ^a   Newell, Kenneth A ^a   Adams, Andrew B ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Cellular rejection; Nonhuman primate; Pig xenografts; Renal transplant; T cell mediated rejection; Xenotransplantation

Indexed keywords

CELL THERAPY; EXPERIMENTAL PIG; GENETIC ENGINEERING; GRAFT REJECTION; GRAFT SURVIVAL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS GRAFT; XENOTRANSPLANTATION; ANIMAL; HUMAN; PIG; PROCEDURES; TRANSGENIC ANIMAL; TRANSPLANTATION; XENOGRAFT;

IMMUNOSUPPRESSIVE AGENT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GRAFT REJECTION; HETEROGRAFTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SWINE; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84949796691     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.07.722     Document Type: Review

References (55)

1. Matas A., Smith J., Skeans M., Thompson B., Gustafson S., Schnitzler M., et al. OPTN/SRTR 2012 annual data report: kidney. Am. J. Transpl. 2014, 14:11-44.
2. Cowan P.J., Cooper D.K.C., D'Apice A.J.F. Kidney xenotransplantation. Kidney Int. 2014, 85:265-275.
3. Cooper D.K.C., Satyananda V., Ekser B., van der Windt D.J., Hara H., Ezzelarab M.B., et al. Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature. Xenotransplantation 2014, 21:397-419. 10.1111/xen.12127.
4. Ekser B., Cooper D.K.C. Overcoming the barriers to xenotransplantation: prospects for the future. Expert Rev. Clin. Immunol. 2010, 6:219-230. 10.1586/eci.09.81.
5. Mohiuddin M., Singh A., Corcoran P., Hoyt R., Thomas M., Ayares D., et al. Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. J. Thorac. Cardiovasc Surg. 2014, 148:1106-1113.
6. Shin J., Kim J., Kim J., Min B., Kim Y., Kim H., et al. Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets. Am. J. Transpl. 2015, 10.1111/ajt.13345.
7. Van Der Windt D.J., Bottino R., Casu a., Campanile N., Smetanka C., He J., et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am. J. Transpl. 2009, 9:2716-2726. 10.1111/j.1600-6143.2009.02850.x.
8. Higginbotham L., Mathews D., Breeden C., Song M., Farris A.B., Larsen C.P., et al. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model. Xenotransplantation 2015, 22:221-230. 10.1111/xen.12166.
9. Iwase H., Liu H., Wijkstrom M., Zhou H., Singh J., Hara H., et al. Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date. Xenotransplantation 2015, 10.1111/xen.12174.
10. Griesemer A., Yamada K., Sykes M. Xenotransplantation: immunological hurdles and progress toward tolerance. Immunol. Rev. 2014, 258:241-258. 10.1111/imr.12152.
11. Scalea J., Hanecamp I., Robson S.C., Yamada K. T-cell-mediated immunological barriers to xenotransplantation. Xenotransplantation 2012, 19:23-30. 10.1111/j.1399-3089.2011.00687.x.
12. Satyananda V., Hara H., Ezzelarab M.B., Phelps C., Ayares D., Cooper D.K.C. New concepts of immune modulation in xenotransplantation. Transplantation 2013, 96:937-945. 10.1097/TP.0b013e31829bbcb2.
13. Yamada K., Sachs D.H., DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J. Immunol. 1995, 155:5249-5256.
14. Dorling A., Lombardi G., Binns R., Lechler R. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur. J. Immunol. 1996, 26:1378-1387.
15. Hering B., Walawalkar N. Pig-to-nonhuman primate islet xenotransplantation. Transpl. Immunol. 2009, 21:81-86.
16. Larsen C.P., Pearson T.C., Adams A.B., Tso P., Shirasugi N., Strobert E., et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am. J. Transpl. 2005, 5:443-453. 10.1111/j.1600-6143.2005.00749.x.
17. Lenschow D., Zeng Y., Thistlethwaite J., Montag A., Brady W., Gibson M., et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992, 257:789-792. (80-. ).
18. Buhler L., Awwad M., Basker M., Gojo S., Watts A., Treter S., et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000, 69:2296-2304.
19. Barth R.N., Yamamoto S., LaMattina J.C., Kumagai N., Kitamura H., Vagefi P.a, et al. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness. Transplantation 2003, 75:1615-1624. 10.1097/01.TP.0000064335.50622.20.
20. Griesemer A., Hirakata A., Shimizu A., Moran S., Tena A., Iwaki H., et al. Results of gal-knockout porcine thymokidney xenografts. Am. J. Transpl. 2009, 9:2669-2678.
21. Shimizu A., Yamada K., Robson S.C., Sachs D.H., Colvin R.B. Pathologic characteristics of transplanted kidney xenografts. J. Am. Soc. Nephrol. 2012, 23:225-235.
22. Lowe M., Badell I., Thompson P., Martin B., Leopardi F., Strobert E., et al. A novel monoclonal antibody to CD40 prolongs islet allograft survival. Am. J. Transpl. 2012, 12:2079-2087. 10.1016/j.biotechadv.2011.08.021.Secreted.
23. Watanabe M., Yamashita K., Suzuki T., Kamachi H., Kuraya D., Koshizuka Y., et al. ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates. Am. J. Transpl. 2013, 13:1976-1988. 10.1111/ajt.12330.
24. Aoyagi T., Yamashita K., Suzuki T., Uno M., Goto R., Taniguchi M., et al. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy. Am. J. Transpl. 2009, 9:1732-1741. 10.1111/j.1600-6143.2009.02693.x.
25. Iwase H., Ekser B., Satyananda V., Bhama J., Hara H., Ezzelarab M., et al. Pig-to-baboon heterotopic heart transplantation - exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens. Xenotransplantation 2015, n/a-n/a. 10.1111/xen.12167.
26. Emamaullee J., Merani S., Larsen C., Shapiro A. Belatacept and basiliximab diminish human antiporcine xenoreactivity and synergize to inhibit alloimmunity. Transplantation 2008, 85:118-124.
27. Nishimura H., Scalea J., Wang Z., Shimizu A., Moran S., Sachs D.H., et al. First experience with the use of a recombinant CD3 immunotoxin as induction therapy in pig-to-priate xenotransplantation: the effect of T-cell depletion on outcome. Transplantation 2011, 92:641-647. 10.1097/TP.0b013e31822b92a5.
28. Phelps C.J., Ball S.F., Vaught T.D., Vance A.M., Mendicino M., Monahan J.a, et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 2009, 16:477-485. 10.1111/j.1399-3089.2009.00533.x.
29. + T-cell responses co-stimulated by porcine and human B7 molecules. Immunology 2011, 134:386-397. 10.1111/j.1365-2567.2011.03496.x.
30. Wang Y., Yang H.-Q., Jiang W., Fan N.-N., Zhao B.-T., Ou-Yang Z., et al. Transgenic expression of human cytoxic T-lymphocyte associated antigen4-Immunoglobulin (hCTLA4Ig) by porcine skin for xenogeneic skin grafting. Transgenic Res. 2015, 24:199-211. 10.1007/s11248-014-9833-9.
31. Plege-Fleck A., Lieke T., Dorothee R., Heike D., Hundrieser J., Buermann A., et al. Pig to rat cell transplantation[U+202F]: reduced cellular and antibody responses to xenografts overexpressing PD-L1. Xenotransplantation 2014, 21:533-542. 10.1111/xen.12121.
32. + Treg cells. J. Leukoc. Biol. 2011, 90:77-86. 10.1189/jlb.1210691.
33. Plege A., Borns K., Baars W., Schwinzer R. Suppression of human T-cell activation and expansion of regulatory T cells by pig cells overexpressing PD-ligands. Transplantation 2009, 87:975-982. 10.1097/TP.0b013e31819c85e8.
34. Hara H., Witt W., Crossley T., Long C., Isse K., Fan L., et al. Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status. Immunology 2013, 140:39-46. 10.1111/imm.12107.
35. Iwase H., Ekser B., Satyananda V., Zhou H., Hara H., Bajona P., et al. Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigs. Transpl. Immunol. 2015, 32:99-108. 10.1016/j.trim.2015.02.003.
36. Tomita Y., Lee L.A., Sykes M. Engraftment of rat bone marrow and its role in negative selection of murine T cells in mice conditioned with a modified nonmyeloablative regimen. Xenotransplantation 1994, 1:109-117.
37. Lee L., Sergio J., Sykes M. Evidence for non-immune mechanisms in the loss of hematopoietic chimerism in rat-mouse mixed xenogeneic chimeras. Xenotransplantation 1995, 2:57-66.
38. Tseng Y.L., Dor F.J.M.F., Kuwaki K., Ryan D., Wood J., Denaro M., et al. Bone marrow transplantation from α1,3-galactosyltransferase gene-knockout pigs in baboons. Xenotransplantation 2004, 11:361-370. 10.1111/j.1399-3089.2004.00151.x.
39. Griesemer A., Liang F., Hirakata A., Hirsh E., Lo D., Okumi M., et al. Occurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KO bone marrow to baboons. Xenotransplantation 2010, 17:300-312.
40. Zhao Y., Sergio J., Swenson K., Arn J., Sachs D., Sykes M. Positive and negative selection of functional mouse CD4 cells by porcine MHC in pig thymus grafts. J. Immunol. 1997, 159:2100-2107.
41. Khan A., Sergio J., Zhao Y., Pearson D., Sachs D., Sykes M. Discordant xenogeneic neonatal thymic transplantation can induce donor-specific tolerance. Transplantation 1997, 63:124-131.
42. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat. Med. 2005, 11:32-34. 10.1038/nm1172.
43. Yamada K., Scalea J. Thymic transplantation in pig-to-nonhuman primates for the induction of tolerance across xenogeneic barriers. Methods Mol. Biol. 2012, 885:191-212.
44. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006, 8:315-317.
45. Li J., Ezzelarab M.B., Ayares D., Cooper D.K.C. The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation. Stem Cell Rev. 2014, 10:79-85. 10.1016/j.biotechadv.2011.08.021.Secreted.
46. Kumar G., Hara H., Long C., Shaikh H., Ayares D., Cooper D.K.C., et al. Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties. Cytotherapy 2012, 14:494-504. 10.3109/14653249.2011.651529.Adipose-derived.
47. Li J., Ezzelarab M.B., Cooper D.K.C. Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation 2012, 19:273-285. 10.1111/xen.12000.DO.
48. McCarthy D., Bryant J., Galvin J., Miller S., Luo X. Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. Am. J. Transpl. 2015, 15:1475-1483.
49. Wang S., Tasch J., Kheradmand T., Ulaszek J., Ely S., Zhang X., et al. Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T-and B-cell tolerance to islet xenografts. Diabetes 2013, 62:3143-3150. 10.2337/db12-1678.
50. Lin Y., Hara H., Tai H., Long C., Tokita D., Yeh P., et al. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation 2008, 86:1452-1462.
51. Lin Y.J., Hara H., Tai H., Long C., Tokita D. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation 2009, 86:1452-1462. 10.1097/TP.0b013e318188acb0.SUPPRESSIVE.
52. Singh A.K., Seavey C.N., Horvath K.A., Mohiuddin M.M. Ex-vivo expanded baboon CD4+ CD25+ Treg cells suppress baboon anti-pig T and B cell immune response. Xenotransplantation 2012, 19:102-111.
53. + Treg cells for potential use in a non-human primate xenotransplantation model. Xenotransplantation 2007, 14:298-308.
54. Wu J., Yi S., Ouyang L. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 2008, 85:1841-1848.
55. Sablinski T., Gianello P., Bailin M. Pig to monkey bone marrow and kidney xenotransplantation. Surgery 1997, 121:381-391.